CIG
BMY icon

CCM Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

CCM Investment Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$5.75M Sell
95,768
-7,872
-8% -$459K 0.61% 27
2024
Q4 		$5.81M Buy
+103,640
New +$5.79M 0.63% 20

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM Investment Group's BMY Position: Q1 2025 in Review

CCM Investment Group reduced its Bristol-Myers Squibb (BMY) stake by 7.6% in Q1 2025, selling an estimated $459K and leaving 95,768 shares worth $5.75M. The position accounts for 0.61% of the portfolio, ranked #27.

CCM Investment Group first reported a position in BMY in Q4 2024 and has held it in 2 quarters since. The position peaked at $5.81M in Q4 2024. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • CCM Investment Group held 95,768 shares of Bristol-Myers Squibb worth $5.75M as of Q1 2025.
  • CCM Investment Group sold 7,872 Bristol-Myers Squibb shares in Q1 2025, an estimated $459K.
  • Bristol-Myers Squibb made up 0.61% of CCM Investment Group's portfolio in Q1 2025, its #27 holding.
  • CCM Investment Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 2 quarters since.
  • CCM Investment Group's Bristol-Myers Squibb position peaked at $5.81M in Q4 2024.
  • 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on CCM Investment Group's 13F filing for Q1 2025, filed 12 May 2025.